Losartan Potassium Tablet, Film Coated
Product Images NDC 33342-044

This is a medication label for Losartan Potassium tablets. The tablets contain 50mg of the active ingredient and are manufactured by Pharma USA. The label provides information on the usual dosage, storage instructions, and precautions. The medication should be kept at room temperature, between 20-25°C, and protected from light. The pharmacist should dispense a Patient Information Leaflet with the pack, and the medication should be kept out of reach of children. The label also includes details on the batch number and expiration date.*

MACLEODY is a medication in tablet form containing 100mg of losartan potassium. It is produced by Pharma USA and should be stored at a temperature between 20°C to 25°C. The standard dosage can be found in the prescribing information. The batch number can be found on the package. Keep out of reach of children, protect from light, and keep the container tightly closed. Contact a pharmacist before taking this medication, and a full patient information leaflet is included in the package. The manufacturer has locations in New Jersey, USA, and Himachal Pradesh, India.*

This is a description of a medication called MACLEODS. Each tablet of MACLEODS contains 25 mg of losartan potassium. The usual dosage is not provided and needs to be checked in the prescribing information. The tablets should be stored in a tightly closed container at a temperature between 20°C to 25°C (68° to 77°F). Protection from light is required, and it should be kept away from children. The manufacturer of this medicine is Macleods Pharma USA, Inc. The package contains 30 tablets.*

MACLEODY tablets contain 25mg of Losartan Potassium, USP and are produced by Macleods Pharma USA. They're typically taken as directed by a healthcare provider and stored between 20°C to 25°C. Patients receiving Losartan should be mindful to follow prescribing information, keeping the product out of reach of children and away from light. A pharmacist should dispense MACLEODY tablets along with a Patient Information Leaflet.*

MACLEODD is a medication available in tablet form that contains 100 mg of T losartan potassium. The usual dosage information can be found in the prescribing NDC 33342-046-07. The tablets should be stored at room temperature between 20° to 25°C and should be protected from light in a tightly closed container. The pharmacist is responsible for dispensing the medicine and the information leaflet is included with the package. The medication is manufactured for Macleods Pharma USA, Inc. by Macleods Pharmaceuticals Ltd in Baddi, Himachal Pradesh, INDIA. No additional information is available.*

This is a description of a medication called Losartan Potassium Tablets, USP made by Macleods Pharma USA. The tablets contain 100 mg of losartan potassium and are typically prescribed according to the information provided in the packaging. The medicine should be stored within a specific temperature range and kept away from light and children. The medication has been manufactured in India and distributed in the US by Macleods Pharma. There is additional information provided such as batch and expiration dates.*

This is a table that shows the overall results of a study that examines the efficacy of Losartan-K and Atenolol in reducing the risk of stroke and other cardiovascular diseases. The results are divided by age, gender, race, presence of diabetes and history of CVD. The table shows the number of patients, rates of events, and hazard ratios for each group. Flavors of Losartan-K and Atenolol are also mentioned but their relevance is unclear.*

MACLEODD tablets contain losartan potassium 25 mg as per the USP standards. The dosage of the tablet is provided in the prescribing information. The tablets must be stored at 20°C to 25°C, with excursions being permitted to 15°C to 30°C. The container must be tightly closed, and the tablets should be kept away from light and out of the reach of children. The pack contains 90 tablets and comes with an information leaflet. The tablets are manufactured by Macleods Pharmaceuticals Ltd in India for Macleods Pharma USA, Inc, in New Jersey.*

MACLEODD is a medication that contains 50mg of losartan potassium, which is used to treat high blood pressure. The usual dosage information can be found in the prescribing information. The tablets should be stored at room temperature and protected from light. The medication is manufactured by Macleods Pharma USA, Inc. and manufactured by Macleods Pharmaceuticals Ltd in India. The package contains 30 tablets and the batch number is HP/152/07 PMO1401103. A patient information leaflet is included in the package.*

MACLEODD tablets contain losartan potassium, USP 50 mg and are taken as per the Dosage and Administration prescribed in the information leaflet. The tablets come in a container and must be stored at a temperature between 20°C to 25°C (68°F to 77°F) with permissible excursions allowed. Losartan Potassium permitted to a temperature between 15°C to 30°C (59°F to 86°F). However, it is important to keep the container tightly closed and away from children. MACLEODD tablets are manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA, Inc. The package contains 90 tablets, and the batch number is HP/152/07 PM01401203. No specific information is available about the usage of the medicine.*

This appears to be a graph or chart representing the percentage of patients who met the primary endpoint in a study comparing Losartan Potassium and Atenolol. The text seems to indicate that an adjusted risk reduction of 13% was observed in the study, and there are time points listed along the x-axis ranging from 12 to 68 months. However, the text is not in a readable format and some characters have been distorted or replaced with symbols, so it may be difficult to interpret without additional context.*

The text describes a study of two medications, Atenolol and Losartan Potassium, in relation to reducing the risk of fatal or non-fatal stroke. The study showed an adjusted risk reduction of 26%, with a p-value of 0.001. The text also includes a graph showing the percentage of patients who experienced a stroke over a period of 86 months.*

This appears to be a visualization of a clinical trial comparing the effects of Losartan Potassium and a placebo on patients over a period of 24 months. The only available data is % of patients with an event and the risk reduction percentage (16.1%) with a p-value of 0.0022. It is unclear what type of events or conditions are being measured in this study.*